zealand_logo_RGB_01.png
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
December 22, 2023 04:30 ET | Zealand Pharma
Press release – No. 18 / 2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Copenhagen, Denmark, December 22, 2023 – Zealand Pharma A/S...
zealand_logo_RGB_01.png
Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)
September 30, 2022 06:15 ET | Zealand Pharma
Company announcement – No. 41 / 2022 Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1) Glepaglutide treatment met the...